Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination
- PMID: 24814432
- DOI: 10.1016/j.ejim.2014.04.010
Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination
Abstract
Background: Tetanus, diphtheria, pertussis and measles are vaccine preventable diseases that have been reported to cause morbidity and mortality in adult population in the recent years. We aimed to document the seropositivity rates and vaccination indication for these four vaccine preventable diseases among adult and elderly patients who were seen as outpatients in a university hospital.
Methods: Blood samples for tetanus, diphtheria, pertussis and measles antibodies were obtained. Results were evaluated with regards to protection levels and booster vaccine indications according to the cut-off values.
Results: A total of 1367 patients consented for the study and 1303 blood samples were available for analysis at the end of the study. The antibody levels against measles conferred protection in 98% of patients. However, 65% of the patients had no protection for diphtheria, 69% had no protection for tetanus and 90% of the patients had no protection for pertussis. Only 1.3% of the study population had seropositivity against three of the diseases-Tdap booster was indicated in 98.7%. Multivariable logistic regression showed that tetanus protection decreased with increasing age. Having a chronic disease was associated with a lower rate of protective antibodies for pertussis.
Conclusions: We demonstrated very low rates of protection against three of the vaccine preventable diseases of childhood-diphtheria, pertussis and tetanus. Booster vaccinations are required in adult life in accordance with national and international adult vaccination guidelines. The concept of "lifelong vaccination" should be implemented and every encounter with the patient should be regarded as a chance for catch-up.
Keywords: Diphtheria; Measles; Pertussis; Seroprevalance; Tetanus; Vaccine.
Copyright © 2014 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Similar articles
-
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.Vaccine. 2012 Aug 10;30(37):5464-71. doi: 10.1016/j.vaccine.2012.06.073. Epub 2012 Jul 6. Vaccine. 2012. PMID: 22776216 Clinical Trial.
-
Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.Vaccine. 2018 Oct 8;36(42):6325-6333. doi: 10.1016/j.vaccine.2018.08.051. Epub 2018 Sep 7. Vaccine. 2018. PMID: 30197282 Clinical Trial.
-
Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US.BioDrugs. 2009;23(4):253-67. doi: 10.2165/11202770-000000000-00000. BioDrugs. 2009. PMID: 19697967 Review.
-
Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents.Int J Infect Dis. 2020 Jul;96:422-430. doi: 10.1016/j.ijid.2020.04.088. Epub 2020 May 6. Int J Infect Dis. 2020. PMID: 32387447
-
Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.Expert Rev Vaccines. 2008 Jul;7(5):621-34. doi: 10.1586/14760584.7.5.621. Expert Rev Vaccines. 2008. PMID: 18564017 Review.
Cited by
-
Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing.Sci Rep. 2018 Aug 29;8(1):13021. doi: 10.1038/s41598-018-31283-y. Sci Rep. 2018. PMID: 30158679 Free PMC article.
-
The maternal antibody against diphtheria, tetanus and pertussis showed distinct regional difference in China.BMC Pediatr. 2019 Dec 7;19(1):480. doi: 10.1186/s12887-019-1860-5. BMC Pediatr. 2019. PMID: 31810436 Free PMC article.
-
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context.Hum Vaccin Immunother. 2020;16(2):340-348. doi: 10.1080/21645515.2019.1652517. Epub 2019 Sep 6. Hum Vaccin Immunother. 2020. PMID: 31403385 Free PMC article.
-
The Present and Future Aspects of Life-Long Pertussis Prevention: Narrative Review with Regional Perspectives for Türkiye.Infect Dis Ther. 2023 Nov;12(11):2495-2512. doi: 10.1007/s40121-023-00876-0. Epub 2023 Oct 10. Infect Dis Ther. 2023. PMID: 37815753 Free PMC article. Review.
-
Pertussis prevalence among adult patients with acute cough.Turk J Med Sci. 2022 Jun;52(3):580-586. doi: 10.55730/1300-0144.5349. Epub 2022 Jun 16. Turk J Med Sci. 2022. PMID: 36326303 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical